Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18 juil. 2024 16h13 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...
Gel Electrophoresis Market Insights Report, 2024-2030 - A Projected $2.5 Billion Global Market with Laboratory Research End-users Accounting for $1.2 Billion
18 juil. 2024 11h42 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Gel Electrophoresis - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gel...
Tissue Engineering Market Size is Expected to Reach USD 12.43 Billion by 2032, Growing at a CAGR of 14.40%: Straits Research
18 juil. 2024 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 18, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global tissue engineering market size was valued at USD 4,333.61 million in 2023. It is...
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA® (omadacycline) for Patients with Moderate to Severe Community-Acquired Bacterial Pneumonia
18 juil. 2024 07h30 HE
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA®
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies
17 juil. 2024 05h15 HE
|
BioProcess360
BioProcess360 Partners announce the launch of a new investment fund to support businesses with the growth of emerging bioprocessing technologies
Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development
17 juil. 2024 03h00 HE
|
Nouscom Srl
BASEL, Switzerland – 17th July 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today...
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
16 juil. 2024 16h01 HE
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation
16 juil. 2024 11h15 HE
|
NeOnc Technologies Holdings, Inc.
FDA approval reflects positive results from Phase I and preliminary results from Phase IIa study currently underway that demonstrate increased survivability rates in patients with the IDH1...
Cell Line Development Market Size to Reach USD 16.28 Billion by 2032 with a CAGR of 9.64%: In-depth Analysis by Product, Source, Type, Applications, and Region
16 juil. 2024 10h10 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 16, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global cell line development market size was valued at USD 6,743.00 million in 2023. It...
2024 Data Exposure Report: Life Sciences Sector Using AI to Fill Skills Gap
16 juil. 2024 09h00 HE
|
Code42 Software, Inc
73% of Life Sciences companies turn to artificial intelligence (AI) to fill the cybersecurity skills gap